| Vilazodone |
| 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide |
| (CAS 163521-12-8) |
 |
| Description： |
Vilazodone (EMD 68843; SB 659746A) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.
IC50 value:
Target: SSRI; 5-HT1A
Vilazodone represents another option for the treatment of MDD. Vilazodone appears to have a favourable weight-gain profile based on short-term studies. Sexual side-effects were not consistently demonstrated when assessed using clinical rating scales but spontaneously reported AEs related to sexual functioning were observed. Additional controlled data regarding long-term efficacy and effectiveness will help characterise this new agent when used in maintenance treatment.
|
| Product No. |
KT20211 |
| Product Name |
Vilazodone |
| Synonyms |
EMD 68843; SB 659746A; EMD-68843; EMD68843; SB-659746A; SB659746A |
| Formal Name |
5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide |
| CAS Number |
163521-12-8 |
| Molecular Formula |
C26H27N5O2 |
| Formula Weight |
441.52 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
5-HT Receptor
Adoprazine
Agomelatine
Almotriptan malate
Alosetron
Alverine citrate
Aripiprazole
Asenapine
Azaphen
Azasetron
Bilobalide
Blonanserin
|
|
